Members of the Cancer Stem Cell Consortium (CSCC) today congratulated Dr. John Dick, a Senior Scientist at the University Health Network and Director of the Cancer Stem Cell Program of the Ontario Institute for Cancer Research, on major new findings published today in the journal Nature.
The Canadian Club of Halton Peel has been presenting guest dinner speakers on a wide range of subjects since 1986.
Under the title “Our Personal Genome – The DNA Dilemma” Dr. Meulien will discuss the importance of Canadian genomic research in sectors such as health, agriculture, environment, forestry and fisheries. He will also address privacy issues arising from the sequencing of the human genome.
Date: Thursday, February 20
Seven new innovative research projects have been funded through Genome BC’s Strategic Opportunities Fund (SOF). The SOF program, with funding provided by Genome BC and several partners, aims to catalyze new projects and initiatives of strategic importance to BC’s economic sectors. These investments are increasingly recognized for providing foundational research and the projects provide an important basis for future research.
Genome Canada and Génome Québec are pleased to announce UCB Canada Inc.’s contribution to a four-year study aimed at developing a personalized medicine approach to the early diagnosis of various types of epilepsy. The $10.8 million project, “Personalized medicine in the treatment of epilepsy”, forms the Canadian Epilepsy Network (CENet) and is led by Dr. Patrick Cossette at the University of Montreal Hospital Research Centre* (CRCHUM), as well as co-leaders, Dr.
Two BC researchers have combined forces to develop a blood test that will identify patients at high risk for Chronic Obstructive Pulmonary Disease (COPD) lung attacks. This much needed test will help medical professionals provide better treatment and ultimately lead to patients with fewer attacks, and reduced hospitalization and emergency visits.
One year ago today marked the beginning of “Genome: The Power and the Promise” — a landmark event, presented by the Gairdner Foundation and Genome Canada, to celebrate a decade of progress and discovery in genomics research.